WASHINGTON, D.C. — The following statement was issued by David Mitchell, a cancer patient and founder of Patients For Affordable Drugs Now, in response to the Senate Judiciary Committee’s bipartisan, unanimous passage of a package of four bills that would lower drug prices and promote innovation by curbing anticompetitive behavior by pharmaceutical corporations: 

“We applaud Chairman Durbin, Ranking Member Grassley, and members of the Senate Judiciary Committee for passing legislation to crack down on anticompetitive drug industry practices and strengthen incentives for true biomedical innovation. This package of bills takes important steps to address abuses of our patent system that inhibit innovation, block competition, and allow drug corporations to raise prices without restraint. 

“Today’s unanimous vote also lends important momentum to the larger work in Congress to fix our broken drug pricing system. We will continue to work with Congress this year to enact other needed reforms, including allowing Medicare to negotiate lower drug prices for all Americans.”